1. How many patients in your area with type 1 diabetes are currently using insulin pump therapy?
2. What percentage of your diabetes population were a) offered and b) received an insulin pump in 2015/2016
3. The total number of patients who were initiated on insulin pump therapy supplied by:
a) Animas
b) Cell-Novo
c) Medtronic
d) Omnipod
e) Roche
4. What was the total spend on insulin pumps and consumables in 2015/2016
5. What guidance, information and structured education do you provide on insulin pumps for
a. providers and
b. patients
6. What choice are providers/patients restricted to in terms of the insulin pumps offered/funded by Maidstone and Tunbridge Wells NHS Trust
